Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011
Aims/hypothesis The aim was to study geographic variations and recent trends in the incidence of end-stage renal disease (ESRD) by diabetes status and type, and in patient condition and modalities of care at initiation of renal replacement therapy. Methods Data from the French population-based dialy...
Gespeichert in:
| Veröffentlicht in: | Diabetologia 2014-04, Vol.57 (4), p.718-728 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 728 |
|---|---|
| container_issue | 4 |
| container_start_page | 718 |
| container_title | Diabetologia |
| container_volume | 57 |
| creator | Assogba, Frank G. A. Couchoud, Cécile Hannedouche, Thierry Villar, Emmanuel Frimat, Luc Fagot-Campagna, Anne Jacquelinet, Christian Stengel, Bénédicte |
| description | Aims/hypothesis
The aim was to study geographic variations and recent trends in the incidence of end-stage renal disease (ESRD) by diabetes status and type, and in patient condition and modalities of care at initiation of renal replacement therapy.
Methods
Data from the French population-based dialysis and transplantation registry of all ESRD patients were used to study geographic variations in 5,857 patients without diabetes mellitus, 227 with type 1 diabetes mellitus, and 3,410 with type 2. Trends in incidence and patient care from 2007 to 2011 were estimated.
Results
Age- and sex-adjusted incidence rates were higher in the overseas territories than in continental France for ESRD unrelated to diabetes and related to type 2 diabetes, but quite similar for type 1 diabetes-related ESRD. ESRD incidence decreased significantly over time for patients with type 1 diabetes (−10% annually) and not significantly for non-diabetic patients (0.2%), but increased significantly for patients with type 2 diabetes (+7% annually until 2009 and seemingly stabilised thereafter). In type 2 diabetes, the net change in the absolute number was +21%, of which +3% can be attributed to population ageing, +2% to population growth and +16% to the residual effect of the disease. Patients with type 2 diabetes more often started dialysis as an emergency (32%) than those with type 1 (20%) or no diabetes.
Conclusions/interpretation
The major impact of diabetes on ESRD incidence is due to type 2 diabetes mellitus. Our data demonstrate the need to reinforce strategies for optimal management of patients with diabetes to improve prevention, or delay the onset, of diabetic nephropathy, ESRD and cardiovascular comorbidities, and to reduce the rate of emergency dialysis. |
| doi_str_mv | 10.1007/s00125-014-3160-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504449947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1504449947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-94a2b4a5c6e5bcd6fc9d206e26ea7ef0d091a0c3788ddba8ea440361c1dc05e83</originalsourceid><addsrcrecordid>eNp1kc2KFTEQhYMoznX0AdxIQAQXRivpdLp7KYOjwoCbEdyF6qT62kP_XFPdi9n5Dr6hT2Lae_1BcJVFfeek6hwhHmt4qQGqVwygTalAW1VoB6q5I3baFkaBNfVdsdvGStfu05l4wHwDAEVp3X1xZqxtXGPsTszXiabIsp_k8pkkHfpIYz8P8_5W4hRlwERy7mTssaWFWI40DP2ysko04EJRZrniBfcksxMOmWRCps3xMuEU6IU0ednvX78Z0PqhuNfhwPTo9J6Lj5dvri_eqasPb99fvL5SwYJZVGPRtBbL4KhsQ3RdaKIBR8YRVtRBhEYjhKKq6xhbrAmthcLpoGOAkuriXDw_-h7S_GUlXvzYc8i740Tzyl6XYHMIja0y-vQf9GZeUz7lJ1VUtjZuM9RHKqSZOVHnD6kfMd16DX5rwx_b8LkNv7Xhm6x5cnJe25Hib8Wv-DPw7AQgBxy6La-e_3B12VjnNiNz5DiPpj2lv1b87-8_AI-1oUY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503748268</pqid></control><display><type>article</type><title>Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Assogba, Frank G. A. ; Couchoud, Cécile ; Hannedouche, Thierry ; Villar, Emmanuel ; Frimat, Luc ; Fagot-Campagna, Anne ; Jacquelinet, Christian ; Stengel, Bénédicte</creator><creatorcontrib>Assogba, Frank G. A. ; Couchoud, Cécile ; Hannedouche, Thierry ; Villar, Emmanuel ; Frimat, Luc ; Fagot-Campagna, Anne ; Jacquelinet, Christian ; Stengel, Bénédicte ; French Renal Epidemiology and Information Network Registry ; on behalf of the French Renal Epidemiology and Information Network (REIN) Registry</creatorcontrib><description>Aims/hypothesis
The aim was to study geographic variations and recent trends in the incidence of end-stage renal disease (ESRD) by diabetes status and type, and in patient condition and modalities of care at initiation of renal replacement therapy.
Methods
Data from the French population-based dialysis and transplantation registry of all ESRD patients were used to study geographic variations in 5,857 patients without diabetes mellitus, 227 with type 1 diabetes mellitus, and 3,410 with type 2. Trends in incidence and patient care from 2007 to 2011 were estimated.
Results
Age- and sex-adjusted incidence rates were higher in the overseas territories than in continental France for ESRD unrelated to diabetes and related to type 2 diabetes, but quite similar for type 1 diabetes-related ESRD. ESRD incidence decreased significantly over time for patients with type 1 diabetes (−10% annually) and not significantly for non-diabetic patients (0.2%), but increased significantly for patients with type 2 diabetes (+7% annually until 2009 and seemingly stabilised thereafter). In type 2 diabetes, the net change in the absolute number was +21%, of which +3% can be attributed to population ageing, +2% to population growth and +16% to the residual effect of the disease. Patients with type 2 diabetes more often started dialysis as an emergency (32%) than those with type 1 (20%) or no diabetes.
Conclusions/interpretation
The major impact of diabetes on ESRD incidence is due to type 2 diabetes mellitus. Our data demonstrate the need to reinforce strategies for optimal management of patients with diabetes to improve prevention, or delay the onset, of diabetic nephropathy, ESRD and cardiovascular comorbidities, and to reduce the rate of emergency dialysis.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-014-3160-9</identifier><identifier>PMID: 24496924</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Chronic illnesses ; Diabetes ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 1 - epidemiology ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epidemiology ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; France - epidemiology ; Hemodialysis ; Hospitals ; Human Physiology ; Humans ; Hypotheses ; Internal Medicine ; Kidney diseases ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - etiology ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Middle Aged ; National health insurance ; Nephrology ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Patients ; Peritoneal dialysis ; Population ; Renal failure ; Renal replacement therapy ; Trends</subject><ispartof>Diabetologia, 2014-04, Vol.57 (4), p.718-728</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-94a2b4a5c6e5bcd6fc9d206e26ea7ef0d091a0c3788ddba8ea440361c1dc05e83</citedby><cites>FETCH-LOGICAL-c402t-94a2b4a5c6e5bcd6fc9d206e26ea7ef0d091a0c3788ddba8ea440361c1dc05e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-014-3160-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-014-3160-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28594669$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24496924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Assogba, Frank G. A.</creatorcontrib><creatorcontrib>Couchoud, Cécile</creatorcontrib><creatorcontrib>Hannedouche, Thierry</creatorcontrib><creatorcontrib>Villar, Emmanuel</creatorcontrib><creatorcontrib>Frimat, Luc</creatorcontrib><creatorcontrib>Fagot-Campagna, Anne</creatorcontrib><creatorcontrib>Jacquelinet, Christian</creatorcontrib><creatorcontrib>Stengel, Bénédicte</creatorcontrib><creatorcontrib>French Renal Epidemiology and Information Network Registry</creatorcontrib><creatorcontrib>on behalf of the French Renal Epidemiology and Information Network (REIN) Registry</creatorcontrib><title>Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis
The aim was to study geographic variations and recent trends in the incidence of end-stage renal disease (ESRD) by diabetes status and type, and in patient condition and modalities of care at initiation of renal replacement therapy.
Methods
Data from the French population-based dialysis and transplantation registry of all ESRD patients were used to study geographic variations in 5,857 patients without diabetes mellitus, 227 with type 1 diabetes mellitus, and 3,410 with type 2. Trends in incidence and patient care from 2007 to 2011 were estimated.
Results
Age- and sex-adjusted incidence rates were higher in the overseas territories than in continental France for ESRD unrelated to diabetes and related to type 2 diabetes, but quite similar for type 1 diabetes-related ESRD. ESRD incidence decreased significantly over time for patients with type 1 diabetes (−10% annually) and not significantly for non-diabetic patients (0.2%), but increased significantly for patients with type 2 diabetes (+7% annually until 2009 and seemingly stabilised thereafter). In type 2 diabetes, the net change in the absolute number was +21%, of which +3% can be attributed to population ageing, +2% to population growth and +16% to the residual effect of the disease. Patients with type 2 diabetes more often started dialysis as an emergency (32%) than those with type 1 (20%) or no diabetes.
Conclusions/interpretation
The major impact of diabetes on ESRD incidence is due to type 2 diabetes mellitus. Our data demonstrate the need to reinforce strategies for optimal management of patients with diabetes to improve prevention, or delay the onset, of diabetic nephropathy, ESRD and cardiovascular comorbidities, and to reduce the rate of emergency dialysis.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Chronic illnesses</subject><subject>Diabetes</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 1 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Epidemiology</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Hemodialysis</subject><subject>Hospitals</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Internal Medicine</subject><subject>Kidney diseases</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>National health insurance</subject><subject>Nephrology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Patients</subject><subject>Peritoneal dialysis</subject><subject>Population</subject><subject>Renal failure</subject><subject>Renal replacement therapy</subject><subject>Trends</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc2KFTEQhYMoznX0AdxIQAQXRivpdLp7KYOjwoCbEdyF6qT62kP_XFPdi9n5Dr6hT2Lae_1BcJVFfeek6hwhHmt4qQGqVwygTalAW1VoB6q5I3baFkaBNfVdsdvGStfu05l4wHwDAEVp3X1xZqxtXGPsTszXiabIsp_k8pkkHfpIYz8P8_5W4hRlwERy7mTssaWFWI40DP2ysko04EJRZrniBfcksxMOmWRCps3xMuEU6IU0ednvX78Z0PqhuNfhwPTo9J6Lj5dvri_eqasPb99fvL5SwYJZVGPRtBbL4KhsQ3RdaKIBR8YRVtRBhEYjhKKq6xhbrAmthcLpoGOAkuriXDw_-h7S_GUlXvzYc8i740Tzyl6XYHMIja0y-vQf9GZeUz7lJ1VUtjZuM9RHKqSZOVHnD6kfMd16DX5rwx_b8LkNv7Xhm6x5cnJe25Hib8Wv-DPw7AQgBxy6La-e_3B12VjnNiNz5DiPpj2lv1b87-8_AI-1oUY</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Assogba, Frank G. A.</creator><creator>Couchoud, Cécile</creator><creator>Hannedouche, Thierry</creator><creator>Villar, Emmanuel</creator><creator>Frimat, Luc</creator><creator>Fagot-Campagna, Anne</creator><creator>Jacquelinet, Christian</creator><creator>Stengel, Bénédicte</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011</title><author>Assogba, Frank G. A. ; Couchoud, Cécile ; Hannedouche, Thierry ; Villar, Emmanuel ; Frimat, Luc ; Fagot-Campagna, Anne ; Jacquelinet, Christian ; Stengel, Bénédicte</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-94a2b4a5c6e5bcd6fc9d206e26ea7ef0d091a0c3788ddba8ea440361c1dc05e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Chronic illnesses</topic><topic>Diabetes</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 1 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Epidemiology</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Hemodialysis</topic><topic>Hospitals</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Internal Medicine</topic><topic>Kidney diseases</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>National health insurance</topic><topic>Nephrology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Patients</topic><topic>Peritoneal dialysis</topic><topic>Population</topic><topic>Renal failure</topic><topic>Renal replacement therapy</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Assogba, Frank G. A.</creatorcontrib><creatorcontrib>Couchoud, Cécile</creatorcontrib><creatorcontrib>Hannedouche, Thierry</creatorcontrib><creatorcontrib>Villar, Emmanuel</creatorcontrib><creatorcontrib>Frimat, Luc</creatorcontrib><creatorcontrib>Fagot-Campagna, Anne</creatorcontrib><creatorcontrib>Jacquelinet, Christian</creatorcontrib><creatorcontrib>Stengel, Bénédicte</creatorcontrib><creatorcontrib>French Renal Epidemiology and Information Network Registry</creatorcontrib><creatorcontrib>on behalf of the French Renal Epidemiology and Information Network (REIN) Registry</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assogba, Frank G. A.</au><au>Couchoud, Cécile</au><au>Hannedouche, Thierry</au><au>Villar, Emmanuel</au><au>Frimat, Luc</au><au>Fagot-Campagna, Anne</au><au>Jacquelinet, Christian</au><au>Stengel, Bénédicte</au><aucorp>French Renal Epidemiology and Information Network Registry</aucorp><aucorp>on behalf of the French Renal Epidemiology and Information Network (REIN) Registry</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>57</volume><issue>4</issue><spage>718</spage><epage>728</epage><pages>718-728</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis
The aim was to study geographic variations and recent trends in the incidence of end-stage renal disease (ESRD) by diabetes status and type, and in patient condition and modalities of care at initiation of renal replacement therapy.
Methods
Data from the French population-based dialysis and transplantation registry of all ESRD patients were used to study geographic variations in 5,857 patients without diabetes mellitus, 227 with type 1 diabetes mellitus, and 3,410 with type 2. Trends in incidence and patient care from 2007 to 2011 were estimated.
Results
Age- and sex-adjusted incidence rates were higher in the overseas territories than in continental France for ESRD unrelated to diabetes and related to type 2 diabetes, but quite similar for type 1 diabetes-related ESRD. ESRD incidence decreased significantly over time for patients with type 1 diabetes (−10% annually) and not significantly for non-diabetic patients (0.2%), but increased significantly for patients with type 2 diabetes (+7% annually until 2009 and seemingly stabilised thereafter). In type 2 diabetes, the net change in the absolute number was +21%, of which +3% can be attributed to population ageing, +2% to population growth and +16% to the residual effect of the disease. Patients with type 2 diabetes more often started dialysis as an emergency (32%) than those with type 1 (20%) or no diabetes.
Conclusions/interpretation
The major impact of diabetes on ESRD incidence is due to type 2 diabetes mellitus. Our data demonstrate the need to reinforce strategies for optimal management of patients with diabetes to improve prevention, or delay the onset, of diabetic nephropathy, ESRD and cardiovascular comorbidities, and to reduce the rate of emergency dialysis.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24496924</pmid><doi>10.1007/s00125-014-3160-9</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-186X |
| ispartof | Diabetologia, 2014-04, Vol.57 (4), p.718-728 |
| issn | 0012-186X 1432-0428 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1504449947 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Aged Aged, 80 and over Biological and medical sciences Chronic illnesses Diabetes Diabetes Mellitus - epidemiology Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Epidemiology Etiopathogenesis. Screening. Investigations. Target tissue resistance Female France - epidemiology Hemodialysis Hospitals Human Physiology Humans Hypotheses Internal Medicine Kidney diseases Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - etiology Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Middle Aged National health insurance Nephrology Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Patients Peritoneal dialysis Population Renal failure Renal replacement therapy Trends |
| title | Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A57%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20the%20epidemiology%20and%20care%20of%20diabetes%20mellitus-related%20end-stage%20renal%20disease%20in%20France,%202007%E2%80%932011&rft.jtitle=Diabetologia&rft.au=Assogba,%20Frank%20G.%20A.&rft.aucorp=French%20Renal%20Epidemiology%20and%20Information%20Network%20Registry&rft.date=2014-04-01&rft.volume=57&rft.issue=4&rft.spage=718&rft.epage=728&rft.pages=718-728&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-014-3160-9&rft_dat=%3Cproquest_cross%3E1504449947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503748268&rft_id=info:pmid/24496924&rfr_iscdi=true |